Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Name change emphasizes the role of metabolic dysfunction in fatty liver disease.
Alcohol-related liver disease is now the number one reason for liver transplants, surpassing hepatitis C and fatty liver disease.
Researchers will conduct a seven-year study and develop an updated archive of data on alcohol and liver health.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
Lockdowns made people feel isolated, depressed, and anxious, leading some to increase their alcohol intake.
Restoration of gut function and microbial diversity could lead to improvement of hepatic encephalopathy.
While hepatitis C remains a leading cause, cirrhosis is increasingly caused by fatty liver disease and alcohol use.
People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.
Study findings suggest people with chronic liver disease should be prioritized for booster shots.
DNA evidence found that Ludwig van Beethoven had a hepatitis B infection during his final months alive.
Researchers suggest cannabis use alone should not be a reason to deny transplants.
Better results were observed even in people with increased portal hypertension.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Women and young adults saw especially large increases between 2019 and 2021.
Current guidelines recommend antiviral treatment regardless of alcohol use.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.